Skip to content
A Green Sign – Lifestyle
Author:
PridCor Therapeutics, LLC
PridCor Therapeutics Announces First Patient Enrolled in Phase 2 SHIELD Study of a Combination Antiviral Regimen for Long COVID
November 10, 2026
PridCor Therapeutics Advances Phase 2 SHIELD Study of a Combination Antiviral Regimen for Long COVID Toward Enrollment
September 24, 2026
WRD 3.0 Becomes China’s First Four-Time Urban Intelligent Driving Champion, WeRide Reports Record Q1 2026 Revenue, up 58% Year over Year
May 13, 2026